NCT05797935View on ClinicalTrials.gov

Evaluation of Changes in Pancreatic Fat Content Using Advanced MR Sequences in Diabetics on Dapagliflozin Therapy

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 1, 2021

Primary Completion Date

December 20, 2022

Study Completion Date

December 31, 2022

Conditions
Pancreatic Lipomatosis
Interventions
DRUG

Dapagliflozin 10mg Tab

Dapagliflozin was given at a dose of 10 mg/day in one group and its effect was observed on the pancreatic fat content

Trial Locations (1)

160012

Deptt of Endocrinology, Chandigarh

All Listed Sponsors
lead

Post Graduate Institute of Medical Education and Research, Chandigarh

OTHER

NCT05797935 - Evaluation of Changes in Pancreatic Fat Content Using Advanced MR Sequences in Diabetics on Dapagliflozin Therapy | Biotech Hunter | Biotech Hunter